All In MedTech

FDA Clearance Tracker · P960004-S060

FINELINE II STEROX LEAD

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 9, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 9, 2013

Approved

Time to decision

75 days

Received Jun 26, 2013. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P960004-S060
Device name
FINELINE II STEROX LEAD
Applicant location
St Paul, MN
Received
Jun 26, 2013
Decided
Sep 9, 2013
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P960004

Device type

Device class
Class III

Every decision under product code NVN

FDA's approval statement

As written in FDA's record.

APPROVAL TO CHANGE THE PRIMER FORMULATION USED ON FINELINE II LEADSUBASSEMBLIES, AS WELL AS TO RELOCATE MANUFACTURING OF SOME SUBASSEMBLIES IN-HOUSE WITH MINOR ASSOCIATED DESIGN CHANGES.

Source documents

Other decisions for Boston Scientific

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.